Red cell alloimmunization in repeatedly transfused children with beta thalassemia major
DOI:
https://doi.org/10.18203/2349-3291.ijcp20171486Keywords:
Alloantibodies, Multiple transfusions, Thalassemia majorAbstract
Background: The development of anti-red blood cell alloantibodies remains a major problem in thalassemia major patients. We studied the frequency of red blood cell (RBC) allo-immunization among Beta thalassemia major patients who received regular transfusions at our center and analyzed the factors, which may be responsible for development of these antibodies.
Methods:An observational study was conducted in department of Pediatric Medicine, SMS Medical College, Jaipur. A total of 150 patients of Beta Thalassemia major who already received multiple transfusions were randomly selected and screening of Red Cell Alloantibodies was done by using SPRCA (solid phase red cell adhesion) method during May 2015 to April 2016. Statistical analysis was done using computer software (SPSS version 20 and primer). The qualitative data were expressed in proportion and percentages and the quantitative data expressed as mean and standard deviations. The difference in proportion was analysed by using chi-square test and the difference in means were analysed by using student t- Test. Significance level for tests were determined as 95% (P <0.05).
Results: Total 150 cases were included. Male female ratio was 1.63:1, 10 cases (6.67%) were positive for alloantibodies. Among these 10 positive cases, 2 had positive family history and 3 had history of splenectomy. In allo-immunised cases mean age, mean age at first transfusion and total number of transfusions were significantly higher in comparison to non-allo-immunized cases.
Conclusions:If patient has red cell alloantibody on regular interval screening then the antibody identification should be performed and corresponding antigen negative blood transfusion is strongly recommended in transfusion dependent thalassemia patients.
References
Michael R. DeBaun, Melissa J. Thalassemia Syndromes. In: Nelson Textbook of Pediatrics. 20th ed. Elsevier. 2016;2349-53.
Hassan K, Ikram N, Dodhy M, Burki UF and Tahir M. Prevalence of beta-thalassemia trait in and around Islamabad. JRMC. 1997;1:18-21.
Rehman M and Lodhi Y. Prospects of future of conservative management of beta-thalassemia major in a developing country. Pak. J. Med. Sci. 2004;20(2):105-7
Singer ST, Wu V, Mignacca R, Kuypers FA, Morel P, Vichinsky EP. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent. Blood. 2000;96:3369-73.
Choudhary R, Sukla JS, Pradhan D, Pahi J. Red Cell Alloimmunization in Multiply Transfused Patients. Indian J Hematol Blood Transfusion. 1997;15( 4):10-2.
Pradhan V, Badakere S, Vasantha K, Koraonkar S, Panjawani S, Jajoo N. Antibodies to red cells in beta thalassemia major patients receiving multiple transfusion. Indian J Hematol Blood transfus. 2001;19(4):100-1.
Sirchia G, Zanella A, Parravicini A, Morelati F, Rebulla P, Masera G. Red cell alloantibodies in thalassemia major. Results of an Italian cooperative study. Transfusion. 1985;25:110-2.
Michail-Merianou V, Pamphili-Panousopoulou L, Piperi-Lowes L, Pelegrinis E, Karaklis A. Alloimmunization to red cell antigens in Thalassemia: Comparative study of usual versus Better-Match Transfusion. Vox Sang. 1987;52:95-8.
Ameen R, Al-Shemmari S, Al-Humood S, Chowdhury RI, Al-Eyaadi O, Al-Bashir A. RBC alloimmunization and autoimmunization among transfusion-dependent Arab thalassemia patients. Transfusion. 2003;43:160410.
El Danasoury AS, Eissa DG, Abdo RM, Elalfy MS. Red blood cell alloimmunization in transfusion-dependent Egyptian patients with thalassemia in a limited donor exposure program. Transfusion. 2012;52:43-7.
Hendrickson JE, Desmarets M, Deshpande SS, Chadwick TE, Hillyer CD, Roback JD, et al. Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Transfusion. 2006;46:1526-36.
Reisner EG, Kostyu DD, Phillips G, Walker C, Dawson DV. Alloantibody responses in multiply transfused sickle cell patients. Tissue Antigens. 1987;30:161-6.
Spanos T, Karageorga M, Ladis V, Peristeri J, Hatziliami A, Kattamis C. Red cell alloantibodies in patients with Thalassemia. Vox Sang. 1990;58:50-5.
Pandey H., Das SS, and Chaudhary R. Red cell alloimmunization in transfused patients: A silent epidemic revisited. Asian J Transfus Sci. 2014;8(2): 75-7.
Rosse WF, Gallagher D, Kinney TR. Transfusion and alloimmunization in sickle cell disease. Blood. 1990;76:1431-7.
Hussein E, Desooky N, Rihan A, Kamal A. Predictors of red cell alloimmunization in multitransfused Egyptian patients with beta-thalassemia. Arch Pathol Lab Med. 2014;138:684-8.
